Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Empathy and Communication Training Program for Psychiatric Nurse Specialists in Saudi Arabia (ECTP) (ECTP)

12 novembre 2026 aggiornato da: Amer Ahmed Amer Alammari, Lincoln University College

Effectiveness of an Empathy and Communication Training Program on Nurse-Reported Therapeutic Engagement Among Psychiatric Nurse Specialists in Saudi Arabia: A Two-Site Quasi-Experimental Study With an Explanatory Sequential Mixed-Methods Design

This study tests whether a five-day Empathy and Communication Training Program (ECTP) helps psychiatric nurse specialists in Saudi Arabia engage better with their patients. Good relationships between nurses and patients are central to mental health care, but structured training in empathy and communication is limited in Saudi psychiatric hospitals.

The ECTP is a face-to-face program of five two-hour sessions (10 hours in total). It covers empathy and communication, the work environment, language and cultural barriers, and emotional preparedness. Sessions use short lectures, role-play, case discussions and group reflection.

The study took place at two psychiatric hospitals. Nurses at the Eradah Complex for Mental Health in Dammam took the ECTP. Nurses at the Eradah Hospital for Mental Health in Madinah attended their usual hospital training sessions instead. Participants were not randomly assigned. The hospital they worked in decided which group they joined.

Nurses at both hospitals completed a 15-item questionnaire about therapeutic engagement before and after the training period. After the program, 15 nurses from the Dammam group were interviewed about how the training affected their work and what barriers remained.

The study aims to find out whether nurses' self-reported therapeutic engagement improves after the ECTP compared with usual training, and to understand nurses' own experiences of the program.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

BACKGROUND The relationship between nurse and patient is a core part of effective psychiatric care. Empathy, active listening, trust and clear communication are its main building blocks. In Saudi Arabia, language and cultural differences within a diverse nursing workforce, together with heavy workloads, can make these relationships harder to build. Structured empathy and communication training for psychiatric nurses is scarce in Saudi hospitals and has rarely been evaluated.

DESIGN This is an explanatory sequential mixed-methods study. The first phase is a quasi-experimental, pre-test/post-test, non-equivalent control-group study. The second phase is a descriptive qualitative study using semi-structured interviews. Participants were assigned to conditions by hospital site rather than individually, because individual randomisation was not feasible (different institutional protocols, geographical separation, the need to keep routine clinical operations running) and to limit contamination between groups.

SETTING AND PARTICIPANTS The intervention site was the Eradah Complex for Mental Health in Dammam (Eastern Region). The control site was the Eradah Hospital for Mental Health in Madinah (Western Region). Both are tertiary psychiatric hospitals providing inpatient, outpatient and addiction services. All eligible psychiatric nurse specialists providing direct patient care at each site were invited to take part. Written informed consent was obtained from all participants.

INTERVENTION The ECTP was developed by the principal investigator with a panel of three experts in psychiatric nursing and nursing education. It was delivered 2 to 6 August 2026 by nurse educators and psychiatric nurse trainers with at least five years of experience in mental health education. Day 1 covered orientation and baseline assessment. Day 2 covered empathy and communication, Day 3 the work environment and training, Day 4 language and cultural barriers, and Day 5 emotional preparedness. Methods included short lectures, role-play, case-based discussion and reflective group activities.

COMPARATOR Control-group nurses attended usual institutional training sessions of their own choosing, lasting 5 to 8 hours, and submitted certificates of attendance. Because this content varied and could include material related to communication or de-escalation, the comparator is usual institutional training and not a no-training control.

DATA COLLECTION Participants completed a paper-based questionnaire in hospital classrooms during working hours, under researcher supervision. The 15-item questionnaire was adapted from the Therapeutic Engagement Questionnaire (used with permission from the developers at Kingston University London) and has four domains: empathy and communication, work environment and training, language and cultural barriers, and emotional preparedness. Items are rated 1 to 5. Three barrier-worded items are reverse-scored so that higher scores always mean more favourable engagement. The questionnaire was given at baseline and immediately after Day 5 for the intervention group, and at an equivalent interval for the control group. Participants created anonymous codes so that their before and after responses could be matched.

After the program, a purposive sample of intervention-group nurses took part in face-to-face interviews of 35 to 55 minutes, audio-recorded with separate written consent. Interviews continued until thematic saturation (15 participants).

SAMPLE SIZE A power analysis (independent-samples t-test, two-tailed, alpha 0.05, power 0.80, Cohen's d 0.50) gave a minimum of 64 participants per group. After finite population correction and a 15% allowance for attrition, the target samples were 66 (Dammam) and 61 (Madinah).

ANALYSIS Quantitative data are analysed with paired and independent-samples t-tests, with non-parametric tests as robustness checks, and with analysis of covariance using baseline score as the covariate. Effect sizes are reported as Cohen's d and partial eta squared. Interview transcripts are analysed with thematic analysis (Braun and Clarke) in NVivo. Quantitative and qualitative findings are integrated using a joint display.

REGISTRATION This study was registered retrospectively, after data collection had finished.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

154

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Al Madinah Province
      • Madinah, Al Madinah Province, Arabia Saudita, 42363
        • Eradah Hospital for Mental Health
    • Eastern Province
      • Dammam, Eastern Province, Arabia Saudita, 32253
        • Eradah Complex for Mental Health

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Currently employed at one of the two study hospitals (Eradah Complex for Mental Health, Dammam, or Eradah Hospital for Mental Health, Madinah)
  • Psychiatric nurse specialist assigned to a psychiatric ward or an outpatient psychiatric or addiction clinic, with direct patient care responsibilities
  • At least six months of psychiatric nursing experience
  • Written informed consent

Exclusion Criteria:

  • Less than six months of psychiatric nursing experience
  • Currently on extended leave (for example maternity leave, sick leave or other long-term absence)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: ECTP (Dammam)

Psychiatric nurse specialists at the Eradah Complex for Mental Health, Dammam, who took part in the five-day ECTP. They completed the therapeutic engagement questionnaire at baseline (Day 1) and immediately after Day 5. Fifteen of these nurses were interviewed afterwards.

Structured five-day, face-to-face training program, two hours per day (10 hours in total), delivered 2-6 August 2026 by nurse educators and psychiatric nurse trainers. Day 1: orientation and baseline assessment. Day 2: empathy and communication. Day 3: work environment and training. Day 4: language and cultural barriers. Day 5: emotional preparedness. Methods: short lectures, role-play, case-based discussion and reflective group activities.

Comparatore attivo: Usual institutional training (Madinah)

Psychiatric nurse specialists at the Eradah Hospital for Mental Health, Madinah, who did not receive the ECTP and attended usual institutional training sessions of their choice (5-8 hours). They completed the same questionnaire at baseline and at an equivalent interval later.

Training sessions of the nurse's own choosing, offered as part of routine hospital education (for example on substance use, personality disorders or trauma-informed care), lasting 5-8 hours. Nurses submitted certificates of attendance.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in overall nurse-reported patient therapeutic engagement (PTE) score
Lasso di tempo: Baseline (Day 1) and immediately after Day 5 of the program (August 2026)

Overall score on the 15-item nurse-reported PTE questionnaire, adapted from the Therapeutic Engagement Questionnaire. Each item is rated from 1 (strongly disagree) to 5 (strongly agree). Items 5, 9 and 10 describe barriers and are reverse-scored (6 minus the original value). The overall score is the mean of all 15 items (range 1 to 5). Higher scores mean more favourable therapeutic engagement. The outcome is the change from baseline to post-test, compared between the intervention group (Dammam) and the control group (Madinah).

Baseline (Day 1) and immediately after Day 5 of the program (August 2026)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Empathy and Communication domain score
Lasso di tempo: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 1 to 3 of the PTE questionnaire (range 1 to 5). Higher scores mean more favourable engagement.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).
Change in Work Environment and Training domain score
Lasso di tempo: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 4 to 8 of the PTE questionnaire (range 1 to 5), with item 5 reverse-scored. Higher scores mean more favourable engagement.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).
Change in Language and Cultural Barriers domain score
Lasso di tempo: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 9 and 10 of the PTE questionnaire (range 1 to 5), both reverse-scored. Higher scores mean fewer perceived barriers.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).
Change in Emotional Preparedness domain score
Lasso di tempo: Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Mean of items 11 to 15 of the PTE questionnaire (range 1 to 5). Higher scores mean more favourable engagement.

Baseline (Day 1) and immediately after Day 5 of the program (August 2026).

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 marzo 2026

Completamento primario (Effettivo)

15 agosto 2026

Completamento dello studio (Effettivo)

18 agosto 2026

Date di iscrizione allo studio

Primo inviato

21 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

21 ottobre 2026

Primo Inserito (Effettivo)

28 ottobre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

12 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • ECTP-DMM-2026

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified questionnaire data (anonymous participant codes, demographic variables and item-level responses) will be shared with qualified researchers on reasonable request to the corresponding author. Interview transcripts and audio recordings will not be shared, to protect participant confidentiality.

Periodo di condivisione IPD

Data will be available after publication of the main results, on request, for 5 years.

Criteri di accesso alla condivisione IPD

Requests should be sent by email to the corresponding author (amer.phdscholar@lincoln.edu.my) with a brief description of the intended use. Access is subject to ethics requirements and to the licensing and permission requirements of the original Therapeutic Engagement Questionnaire.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .